A Parallel-Group Comparative Open-Label Study of Long-Acting Injectible Risperidone Versus Risperidone Tablets in Patients With Schizophrenia.
Phase of Trial: Phase III
Latest Information Update: 30 Mar 2010
At a glance
- Drugs Risperidone (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors Janssen Pharmaceutical KK
- 30 Mar 2010 Actual patient number (205) added as reported by ClinicalTrials.gov.
- 07 Aug 2008 New trial record.